APA (7th ed.) Citation

Boden, E. K., Kongala, R., Hindmarch, D. C., Shows, D. M., Juarez, J. G., & Lord, J. D. (2024). Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells. Inflammatory bowel diseases, 30(5), 704-717. https://doi.org/10.1093/ibd/izad224

Chicago Style (17th ed.) Citation

Boden, Elisa K., Ramya Kongala, Duncan C. Hindmarch, Donna M. Shows, Julius G. Juarez, and James D. Lord. "Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells." Inflammatory Bowel Diseases 30, no. 5 (2024): 704-717. https://doi.org/10.1093/ibd/izad224.

MLA (9th ed.) Citation

Boden, Elisa K., et al. "Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells." Inflammatory Bowel Diseases, vol. 30, no. 5, 2024, pp. 704-717, https://doi.org/10.1093/ibd/izad224.